Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007

Yoshihiko Segawa,Katsuyuki Kiura,Nagio Takigawa,Haruhito Kamei,Shingo Harita,Shunkichi Hiraki,Yoichi Watanabe,Keisuke Sugimoto,Takuo Shibayama,Toshiro Yonei,Hiroshi Ueoka,Mitsuhiro Takemoto,Susumu Kanazawa,Ichiro Takata,Naoyuki Nogami,Katsuyuki Hotta,Akio Hiraki,Masahiro Tabata,Keitaro Matsuo,Mitsune Tanimoto

Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007

2010

Purpose To demonstrate the efficacy of docetaxel and cisplatin (DP) chemotherapy with concurrent thoracic radiotherapy (TRT) for patients with locally advanced non–small-cell lung cancer (LA-NSCLC).

Keywords:

Vindesine
Respiratory disease
Cisplatin
Cancer
Pathology
Lung cancer
Radiation therapy
Docetaxel
Chemotherapy
Medicine
combination chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

182

Citations